
An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …

AstraZeneca’s investigational respiratory drug has posted positive results in a Phase III trial in people with COPD, having found it …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

